- Exchange: Helsinki
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Orion OYJ (ORNBV)
| Open: | 20.9800 | Day's Range: | 20.7600 - 21.3000 | Volume: | 291,322 |
|---|---|---|---|---|---|
| Previous Close: | 20.7800 | 52wk Range: | 13.3100 - 24.5800 | 1-Yr Rtn: | +52.23% |
Key Statistics for ORNBV
| Current P/E Ratio (ttm) | 14.2939 |
|---|---|
| Estimated P/E(12/2013) | 14.9928 |
| Relative P/E vs. HEXP | 0.2493 |
| Earnings Per Share (EUR) (ttm) | 1.4538 |
| Est. EPS (EUR) (12/2013) | 1.3860 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 2,927.72 |
| Shares Outstanding (M) | 98.95 |
| 30 Day Average Volume | 294,034 |
| Price/Book (mrq) | 7.6678 |
| Price/Sale (ttm) | 2.9813 |
| Dividend Indicated Gross Yield | 6.26% |
| Cash Dividend (EUR) | 1.3000 |
| Last Dividend | 03/20/2013 |
| 5 Year Dividend Growth | 5.39% |
| Next Earnings Announcement | 07/30/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ORNBV
Company Profile & Key Executives for ORNBV
Orion Oyj develops and manufactures pharmaceuticals and diagnostic kits. The Company produces hormone therapies and drugs to treat central nervous system disorders, cardiovascular diseases and urological disorders, and in vitro diagnostic kits used in doctor's offices and small laboratories.
| Hannu SyrjaenenChairman | Jukka YlppoVice Chairman |
| Timo LappalainenPresident/CEO | Jari KarlsonChief Financial Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ORNBV News
-
Industry News
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page